Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

Selective uptake of medicines outside China's National Reimbursement Drug List by commercial specialty-drug rosters: a multi-product audit of the 2020–2025 negotiation cohorts
Дата публикации: 21-10-2026 08:40:09

An article created on 2026-10-21 08:40:09

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Enhancing Multidimensional Quality in Chinese Tertiary Hospital Clinical Departments Through a Dedicated Quality Supervisor System: A Seven-Year Phase-Controlled Longitudinal Study019.1720-08-2026
2Enrollment cuts and primary-outcome changes, not completion-date delays, predict the termination of industry phase 2–3 drug trials: a landmark analysis of ClinicalTrials.gov version histories019.0122-10-2026
3Antiangiogenic Class and Trial Population Are Confounded in First- Line Immunotherapy for Hepatocellular Carcinoma: A Bayesian Network Meta-Analysis of Nine Randomised Trials017.1421-10-2026
4Narrowing the Innovation Gap: Cross-Regional University Leadership Transfers and Research Performance in Western China02022-10-2026
5Construction of a nursing quality evaluation indicator system for extubation of endotracheal tube in the Postanesthesia care unit in China: A Delphi study011.1321-10-2026
6EYE CHOOSE: An economic evaluation of surgical strategies for retinal detachment014.3921-10-2026
7Governing the resilient city agenda: an Elliptical Focus Resonance model of health sector engagement in China013.4511-08-2026
8Patient Preferences for Non-Opioid Regimens in Chronic Non-Cancer Pain: A Systematic Review of Discrete Choice Experiments023.6410-08-2026
9An auditable decision framework for donor–acceptor materials screening015.2620-08-2026
10後発医薬品のある先発医薬品（長期収載品）の選定療養について01014-10-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 19.63. Источник: www.researchsquare.com.